These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14405795)

  • 1. Fatal exfoliative dermatitis following injection of triple antigen and Salk vaccine.
    IAMS AM
    Am J Dis Child; 1960 Aug; 100():282-5. PubMed ID: 14405795
    [No Abstract]   [Full Text] [Related]  

  • 2. Salk polio vaccine; comments concerning administration to allergic children.
    CRUMP J
    J Am Med Womens Assoc; 1956 Jul; 11(7):255. PubMed ID: 13345646
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactions to the salk polio vaccine injections of April 1955.
    DAVIS PL
    Med Times; 1956 Jul; 84(7):707-9. PubMed ID: 13347478
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of Rh sensitivity after repeated injections of Salk vaccine.
    ABELSON NM; MCALLISTER RM; GREENE A; CORIELL LL
    J Am Med Assoc; 1955 Sep; 159(4):238-41. PubMed ID: 13251868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reactions, complications and contraindications in the Salk antipoliomyelitis vaccination].
    MARASS I
    Inf Med; 1961 May; 16():151-5. PubMed ID: 14469554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formation and persistence of antibodies against poliomyelitis after vaccinations with Salk vaccine. A contribution to the value and limitations of Salk vaccinations].
    BUERGIN-WOLFF A; BERGER E
    Schweiz Med Wochenschr; 1960 Jun; 90():633-7. PubMed ID: 13805708
    [No Abstract]   [Full Text] [Related]  

  • 7. [On neutralizing antibodies before and after vaccination against poliomyelitis with Salk vaccine].
    GILLERT KE; GRUETZNER L; HARTMANN H
    Zentralbl Bakteriol; 1960 Feb; 177():289-98. PubMed ID: 13850076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exacerbation of atopic dermatitis by antipoliomyelitic vaccine].
    ASRILANT M; INGLESINI C; DE SCHNIR RE
    Sem Med; 1961 Nov; 119():1769-70. PubMed ID: 13862945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report on the Salk vaccine].
    VIVELL
    Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):121-8. PubMed ID: 13321822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Considerations for the implementation of the Salk vaccine].
    BUSTAMANTE W
    Rev Chil Pediatr; 1956 Mar; 27(3):123-7. PubMed ID: 13350716
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Salk vaccine].
    DE ARAGAO RM
    J Pediatr (Rio J); 1955 Nov; 20(11):634-55. PubMed ID: 13294937
    [No Abstract]   [Full Text] [Related]  

  • 12. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the effectiveness of Salk vaccine in Alberta with special reference to the outbreak of poliomyelitis in 1960.
    SMITH ES
    Can J Public Health; 1961 Nov; 52():467-73. PubMed ID: 13914212
    [No Abstract]   [Full Text] [Related]  

  • 14. Unpredictability of antibody response of infants to injections of Salk poliomyelitis vaccine.
    CRAMBLETT HG; FOMON SJ
    J Pediatr; 1961 Jun; 58():779-84. PubMed ID: 13696225
    [No Abstract]   [Full Text] [Related]  

  • 15. A community vaccination program. A report on the introduction and subsequent use of Salk polio vaccine in Omaha and Douglas County.
    LYMAN ED; ADAMS B
    Nebr State Med J; 1962 May; 47():290-6. PubMed ID: 14467569
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the Food and Drug Administration in the control of the Salk vaccine.
    CHECCHI AA
    Antibiot Chemother (Northfield); 1956 Apr; 6(4):257-9. PubMed ID: 24543956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fatal encephalitis after poliomyelitis vaccination].
    ZISCHINSKY H; PENDL O; KUNZ C; JELLINGER K
    Klin Wochenschr; 1961 Jun; 39():638-45. PubMed ID: 13788641
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against poliomyelitis in Poland with types 1 and 3 attenuated viruses of Koprowski. 1. Virological studies of the vaccine strains and serological studies of the vaccinated population.
    PRZESMYCKI F; DOBROWOLSKA H; MIRSKI B; WIOR H; STANCZYK R; ZALESKA H
    Bull World Health Organ; 1962; 26(6):733-43. PubMed ID: 14489069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction to poliomyelitis vaccine; case report.
    CLYDE WA
    Arch Pediatr (N Y); 1956 Aug; 73(8):278-9. PubMed ID: 13363564
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to poliomyelitis in Guatemala: a serological and virological survey.
    HORSTMANN DM; SAENZ AC; OPTON EM
    Bull World Health Organ; 1960; 22(3-4):255-62. PubMed ID: 14403224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.